New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
By Dennis Thompson HealthDay ReporterTUESDAY, May 5, 2026 (HealthDay News) — A new combination drug therapy could help people with inflammatory bowel disease (IBD) for whom other medicines have stopped working, according to a pair of new studies. The treatment combines two drugs already approved to treat inflammatory diseases, guselkubam (Tremfya) and golimumab (Simponi), researchers …